CN103432483A - 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 - Google Patents
一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 Download PDFInfo
- Publication number
- CN103432483A CN103432483A CN2013103675517A CN201310367551A CN103432483A CN 103432483 A CN103432483 A CN 103432483A CN 2013103675517 A CN2013103675517 A CN 2013103675517A CN 201310367551 A CN201310367551 A CN 201310367551A CN 103432483 A CN103432483 A CN 103432483A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- blood stasis
- radix
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 57
- 210000004369 blood Anatomy 0.000 title claims abstract description 57
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 230000001154 acute effect Effects 0.000 title claims abstract description 22
- 210000001099 axilla Anatomy 0.000 title abstract description 6
- 238000000034 method Methods 0.000 title abstract description 6
- 201000009052 suppurative lymphadenitis Diseases 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 241000218176 Corydalis Species 0.000 claims abstract description 7
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 24
- 201000003265 lymphadenitis Diseases 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 241000563984 Ampelopsis Species 0.000 claims description 6
- 241000959626 Calvatia Species 0.000 claims description 6
- 241000237903 Hirudo Species 0.000 claims description 6
- 241000045019 Huechys sanguinea Species 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 6
- 241001250596 Pleione Species 0.000 claims description 6
- 241000218206 Ranunculus Species 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 10
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 240000005748 Achyranthes aspera Species 0.000 abstract 1
- 235000005517 Achyranthes aspera Nutrition 0.000 abstract 1
- 241000054262 Cassytha capillaris Species 0.000 abstract 1
- 244000237507 Dioscorea hispida Species 0.000 abstract 1
- 235000009979 Dioscorea hispida Nutrition 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000048199 Hibiscus mutabilis Species 0.000 abstract 1
- 235000003973 Hibiscus mutabilis Nutrition 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000208672 Lobelia Species 0.000 abstract 1
- 241000133231 Marshallia caespitosa Species 0.000 abstract 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 241000691155 Pteris multifida Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000000664 Rosa chinensis Nutrition 0.000 abstract 1
- 235000016785 Rosa della China Nutrition 0.000 abstract 1
- 240000003377 Shepherdia canadensis Species 0.000 abstract 1
- 235000018324 Shepherdia canadensis Nutrition 0.000 abstract 1
- 235000001238 Solanum aculeastrum Nutrition 0.000 abstract 1
- 241000047359 Solanum aculeastrum Species 0.000 abstract 1
- 235000002594 Solanum nigrum Nutrition 0.000 abstract 1
- 240000002307 Solanum ptychanthum Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 239000001269 achillea millefolium l. oil Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 239000004922 lacquer Substances 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Inorganic materials O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 41
- 230000001737 promoting effect Effects 0.000 description 36
- 231100000614 poison Toxicity 0.000 description 32
- 239000003440 toxic substance Substances 0.000 description 27
- 235000009508 confectionery Nutrition 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 20
- 230000017531 blood circulation Effects 0.000 description 19
- 210000002216 heart Anatomy 0.000 description 16
- 208000004880 Polyuria Diseases 0.000 description 15
- 230000035619 diuresis Effects 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 230000023597 hemostasis Effects 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 230000008961 swelling Effects 0.000 description 12
- 230000001939 inductive effect Effects 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 210000002429 large intestine Anatomy 0.000 description 8
- 230000007096 poisonous effect Effects 0.000 description 8
- 208000026935 allergic disease Diseases 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 230000002175 menstrual effect Effects 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000010949 lymph node disease Diseases 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法,属于中药制备方法技术领域。目前治疗瘀血型腋下急性化脓性淋巴结炎一般采用抗菌素及磺胺类药物,其缺点是毒副作用大。该发明的技术方案为:取一枝蒿、三棱、干漆、土牛膝、大血藤、川芎、川牛膝、王不留行、无名异、五灵脂、月季花、凤仙花、水蛭、地锦草、延胡索、马勃、马齿苋、马蔺子、天茄子、无爷藤、无患子、木芙蓉花、瓦松、毛莨、凤尾草、水蓼、龙葵、白蔹、白毛藤、白薯莨、玄参、半边莲、草血竭和甘草,将以上中药放入水中浸泡,然后文火煎制,过滤去渣煎出的药液即为治疗瘀血型腋下急性化脓性淋巴结炎的中药。它的优点是:制成的中药毒副作用小,疗程短,治愈率高。
Description
技术领域
本发明涉及中药制备方法技术领域,更具体的讲是一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法。
背景技术
目前治疗瘀血型腋下急性化脓性淋巴结炎,一般采用:
1、头孢噻肟:肌注局部可有疼痛;静注时可有血栓性静脉炎发生;皮疹、药物热等变态反应。
2、羧苄西林:可以出现各种类型的变态反应。大剂量给药后可能引起神经毒反应、肺水肿,用药期间可能出现短暂性转氨酶升高与粒细胞减少。
3、氨苄西林:大量口服常出现胃肠道不适。肌注局部有疼痛。无论口服或注射均可引起变态反应,以皮疹为多见。用药前必须先做皮试。
4、哌拉西林:肌注后偶有局部疼痛,快速静脉推注可导致暂时性恶心、胸闷、咳嗽、发热、口腔异味、眼结膜充血,变态反应(皮疹、痒感、头晕、麻木、发热等),用药前必须注意青霉素有无过敏史,并做青霉素皮试。
5、阿莫西林:偶见皮疹,口服大量后可有恶心、上腹部不适、腹泻等;伪膜性结肠炎。
6、青霉素:本品易发生变态反应,特别是过敏性休克(最危险的过敏性休克,可发生在做皮肤试验的当时,极少数可发生在连续用药过程中,迟发性过敏性休克),如不及时抢救,可危急生命,故用药前、中、后都要提高防护,以免发生意外。注意:应用前,必须问清有无过敏性疾病,用青霉素后有无皮疹、发热等变态反应出现,务必先做青霉素皮试。
7、氨曲南:偶有味觉异常、皮疹、轻度胃肠道反应,肌注局部疼痛,静注可出现静脉炎。
8、卡那霉素:本品对听神经和肾脏均有毒性,前者表现为耳鸣、听力减退、甚至永久性耳聋(因以前庭损害为主,故比较严重),为此对老年人、孕妇(可影响胎儿)必须高度警惕为孕;后者表现为蛋白尿、管型尿等。
9、采用磺胺甲恶唑患者有时引起胃肠道反应、结晶尿、血尿、皮疹、药热及白细胞减少。
10、头孢哌酮:肌注局部可有疼痛;偶见皮疹、药物热等变态反应;个别病人可出现全血细胞减少、一过性转氨酶升高、凝血酶原时间延长或出血等。
发明内容
为克服上述缺点,本发明的目的是发明一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法。瘀血型腋下急性化脓性淋巴结炎,属于祖国医学“腋痛”“夹肢痛”“夹痛”的范畴。腋下暴肿、灼热、疼痛而皮色不变,发热恶寒,上肢举动不利,二周成脓,易敛。《医宗金鉴·外科心法要诀·腋痈》云:“腋痈暴肿生腋间,肿硬火欣赤痛热寒,肝脾血热兼忿怒,初宜清解溃补痊。”
病因病机:由于情志不畅,肝郁气滞,“气行则血行”,“气滞则血凝”,引起瘀血,气滞日久化火,淋巴结的功能失调,引起本病。
临床表现:局部刺痛,固定不移,拒按。1、初期:初起腋下多暴肿,皮色不变,灼热疼痛,同时上肢活动不利,伴有发热,纳呆,舌质暗,脉涩等症状。2、成脓:若疼痛日增,寒热不退,势在酿脓,消散的很少。经10~14天肿块中间变软,皮色转红,按之波动明显时,此为内脓已成。
它的技术方案为:取一枝蒿3重量份、三棱5重量份、干漆6重量份、土牛膝2重量份、大血藤3重量份、川芎1重量份、川牛膝2重量份、王不留行6重量份、无名异5重量份、五灵脂6重量份、月季花5重量份、凤仙花6重量份、水蛭2重量份、地锦草6重量份、延胡索5重量份、自然铜6重量份、刘寄奴1重量份、红花6重量份、红娘子2重量份、杜鹃花6重量份、芸薹子1重量份、苏木6重量份、皂角刺4重量份、没药6重量份、鸡血藤3重量份、山豆根6重量份、山慈姑6重量份、千层塔6重量份、小檗2重量份、马勃6重量份、马齿苋5重量份、马蔺子6重量份、天茄子6重量份、无爷藤8重量份、无患子6重量份、木芙蓉花6重量份、瓦松3重量份、毛莨1重量份、凤尾草6重量份、水蓼2重量份、龙葵6重量份、白蔹5重量份、白毛藤6重量份、白薯莨1重量份、玄参2重量份、半边莲6重量份、草血竭3重量份和甘草9重量份,将以上48味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗瘀血型腋下急性化脓性淋巴结炎的中药。
该发明的优点是:本方48味中药,在药店均能买到,制作简单,制成的中药液毒副作用小,疗程短,治愈率高。君臣佐使,恰到好处。应用中药的同时,避免了西药磺胺药、抗菌素引起的不良反应、过敏反应和毒性反应。一枝蒿、三棱、干漆、土牛膝、大血藤、川芎、川牛膝、王不留行、无名异、五灵脂、月季花、凤仙花、水蛭、地锦草、延胡索、自然铜、刘寄奴、红花、红娘子、杜鹃花、芸薹子、苏木、皂角刺、没药、鸡血藤,以上25味药具有清热解毒、利尿通淋、凉血止血,利水消肿、理气止痛、行瘀排脓之功效。在治疗瘀血型腋下急性化脓性淋巴结炎的过程中,起主要治疗作用,故为君药。山豆根、山慈姑、千层塔、小檗、马勃、马齿苋、马蔺子、天茄子、无爷藤、无患子、木芙蓉花、瓦松、毛莨、凤尾草、水蓼、龙葵、白蔹、白毛藤、白薯莨、玄参、半边莲,以上21味药具有凉血解毒,行血通络, 清热燥湿之功效。在治疗瘀血型腋下急性化脓性淋巴结炎的过程中,能辅助主药发挥治疗作用,故为臣药。草血竭:辛、苦,微温,微涩。入脾、胃、肾三经。活血散血,和胃止痛,下气消食,消痞散结,利尿消肿。能率诸药直达病灶,故为佐药。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。既能纠诸药之偏性,又能缓解诸药之毒性,故为使药。一枝蒿、三棱、干漆、土牛膝、大血藤、川芎、川牛膝、王不留行、无名异、五灵脂、月季花、凤仙花、水蛭、地锦草、延胡索、自然铜、刘寄奴、红花、红娘子、杜鹃花、芸薹子、苏木、皂角刺、没药、鸡血藤、山豆根、山慈姑、千层塔、小檗、马勃、马齿苋、马蔺子、天茄子、无爷藤、无患子、木芙蓉花、瓦松、毛莨、凤尾草、水蓼、龙葵、白蔹、白毛藤、白薯莨、玄参、半边莲、草血竭、甘草,这48味药配伍应用,共同起到清热解毒、利尿通淋、凉血止血,利水消肿、理气止痛、行瘀排脓、凉血解毒,行血通络, 清热燥湿之功效。君臣佐使,配伍得当,是治疗瘀血型腋下急性化脓性淋巴结炎的最佳配方。一枝蒿:辛、苦,微温,有毒。入心、肝、肺三经。活血消癥,祛风止痛,解毒消肿,散瘀通络。三棱:苦、辛,平,无毒。入肝、脾二经。破血祛瘀,行气止痛,消积和胃。干漆:辛、苦,温,有毒。入肝、脾二经。活血通经,消积杀虫。土牛膝:苦、酸,平。入心、肝、大肠三经。活血散瘀,清热解毒,祛湿利尿。大血藤:苦、涩,平。入肝、大肠二经。活血通经,清热解毒,祛风杀虫。川芎:辛、苦,温。入肝、胆、膀胱、三焦经。行气开郁,祛风燥湿,活血止痛,消肿排脓。川牛膝:甘、微苦,平,无毒。入肝、肾二经。祛风利湿,利湿通淋,活血通络。王不留行:苦,平。入肝、胃二经。活血通经,通络下乳,消肿敛疮,利水通淋。无名异:甘,平。入肾、肝二经。去瘀止痛,消肿生肌,下乳。五灵脂:苦、甘,温。入肝、脾二经。散瘀止痛,活血止血,解毒,健脾消积。月季花:甘,温。入肝经。活血调经,消肿解毒。凤仙花:甘、微苦,温。入肝经。活血通经,祛风止痛。水蛭:咸、苦,平、有小毒。入肝经。破血逐瘀。地锦草:苦、辛,平,涩。入肺、肝、胃、大肠、膀胱五经。活血止血,清热解毒,利湿退黄,通乳,疳积。延胡索:辛、苦,温。入心、肝、脾三经。活血行气,活血散瘀。自然铜:辛、苦,平。入肝、肾二经。散瘀止痛,接筋续骨。刘寄奴:苦,温。入心、肝、脾三经。破血通经,散瘀止痛,醒脾消食。红花:辛,温。入心、肝二经。活血祛瘀,通经止痛,调血和血。红娘子:苦、辛,平,有毒。入肝、胃二经。活血通瘀,攻毒破积。杜鹃花:辛、甘、酸,温。入肝、脾、肾三经。活血止血,祛风除湿。芸薹子:辛,温,无毒。入肝、肾二经。破气行血,消肿散结。苏木:甘、咸,平。入肝、胃、大肠三经。行血破瘀,消肿止痛。皂角刺:辛,温。入肝、肺二经。消肿排脓,搜风拔毒,行气理气。没药:苦、辛,平。入心、肝、脾、肾四经。散血祛瘀,活血止血,生肌治痿,坠胎,疗目祛翳。鸡血藤:苦、甘,温。入心、脾二经。活血化瘀,舒筋通络,补中暖胃。山豆根:苦,寒。入心、肺、大肠三经。清热解毒,消肿止痛。山慈姑:甘、微辛,寒。入肝、脾、肺三经。解毒消肿,散结化痰。千层塔:辛、甘、酸、微苦、平,无毒。入肺、大肠、肝、肾四经。清热解毒,燥湿敛疮,止血定痛。小檗:苦、寒。入肺、肝、脾三经。清热燥湿,泻火解毒。马勃:辛,平。入肺、肝二经。清肺利咽,止血,消痈敛疮。马齿苋:酸,寒。入大肠、肝、脾三经。清热利湿,凉血解毒,止消渴,治目盲白翳。马蔺子:甘,平。入脾、胃、肺三经。清热利湿,解毒消肿,凉血止血,祛湿通痹,健脾和胃。天茄子:苦,寒。入肺、胃二经。清热泻火,祛风止痛。无爷藤:甘、苦,寒。入肝、肾二经。清热利湿,凉血解毒。无患子:苦、微辛,寒,有小毒。入心、肺二经。清热解毒,止咳化痰,消积杀虫,燥湿束带。木芙蓉花:辛、苦、甘,平。入肝、肺二经。清热解毒,凉血止血,消肿止痛。瓦松:酸、苦、凉。入肝、肺二经。清热解毒,凉血止血,清热利湿。毛莨:辛,温,有毒。入肝、胆、心、胃四经。利湿退黄,温寒止痛,散寒通滞。凤尾草:甘、淡、微苦,寒。入大肠、肾、心、肝四经。清热利湿,凉血止血,消肿解毒。水蓼:辛,温。入心经。祛湿止泻,散瘀止痛,解毒消肿,杀虫疗疮。龙葵:甘、微甘,寒;有小毒。入肺、肝、胃三经。清热解毒,活血消肿,化痰解痉,清肝明目,祛风止痒。白蔹:苦、甘、辛,微寒。入心、肝、胃三经。消热解毒,理气散结,凉血止血,熄风止惊,生肌止痛。白毛藤:甘、苦,寒。入肝、脾二经。清热解毒,利湿消肿,活血止痛,祛风止痒。白薯莨:苦,寒,有毒。入肺、肝二经。清热解毒,消肿止痛。玄参:苦、甘、咸,寒。入肺、心、肾三经。清热解毒,滋阴降火,散结消痈。半边莲:辛、甘淡,平。入心、小肠、肺三经。清热解毒,利水消肿,治疗疳积,风湿痛。草血竭:辛、苦,微温,微涩。入脾、胃、肾三经。活血散血,和胃止痛,下气消食,消痞散结,利尿消肿。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。
具体实施方式:
取一枝蒿3g、三棱5g、干漆6g、土牛膝2g、大血藤3g、川芎1g、川牛膝2g、王不留行6g、无名异5g、五灵脂6g、月季花5g、凤仙花6g、水蛭2g、地锦草6g、延胡索5g、自然铜6g、刘寄奴1g、红花6g、红娘子2g、杜鹃花6g、芸薹子1g、苏木6g、皂角刺4g、没药6g、鸡血藤3g、山豆根6g、山慈姑6g、千层塔6g、小檗2g、马勃6g、马齿苋5g、马蔺子6g、天茄子6g、无爷藤8g、无患子6g、木芙蓉花6g、瓦松3g、毛莨1g、凤尾草6g、水蓼2g、龙葵6g、白蔹5g、白毛藤6g、白薯莨1g、玄参2g、半边莲6g、草血竭3g和甘草9g,将以上48味药一起放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣,煎出的药液即为治疗瘀血型腋下急性化脓性淋巴结炎的中药。共煎药液390毫升,当瘀血型腋下急性化脓性淋巴结炎的病人需要治疗时,使药液温度为35℃,每次130毫升,口服,每日三次, 二日为一疗程,若症状仍存,再服第二疗程,以至痊愈。
389例瘀血型腋下急性化脓性淋巴结炎患者中,男性263例,占67.6%;女性126例,占32.4%。男性多于女性。
表一、389例瘀血型腋下急性化脓性淋巴结炎患者的年龄范围
| 年龄(岁) | 20~30 | 31~40 | 41~50 | 51~60 |
| 例数 | 11 | 249 | 112 | 17 |
| 百分比 | 2.8% | 64% | 28.8% | 4.4% |
表二、389例瘀血型腋下急性化脓性淋巴结炎患者疗效表
| 疗效 | 治愈 | 好转 | 无效 |
| 例数 | 386 | 3 | 无 |
| 百分比 | 99.2% | 0.8% | 无 |
表三、389例瘀血型腋下急性化脓性淋巴结炎患者疗程表
| 治疗天数 | 3~5 | 6~9 | 10~14 | 15~26 |
| 例数 | 12 | 229 | 131 | 17 |
| 百分比 | 3% | 58.9% | 33.7% | 4.4% |
表四、389例瘀血型腋下急性化脓性淋巴结炎患者治疗前后情况表
Claims (1)
1. 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法,其特征是:取一枝蒿3克、三棱5克、干漆6克、土牛膝2克、大血藤3克、川芎1克、川牛膝2克、王不留行6克、无名异5克、五灵脂6克、月季花5克、凤仙花6克、水蛭2克、地锦草6克、延胡索5克、自然铜6克、刘寄奴1克、红花6克、红娘子2克、杜鹃花6克、芸薹子1克、苏木6克、皂角刺4克、没药6克、鸡血藤3克、山豆根6克、山慈姑6克、千层塔6克、小檗2克、马勃6克、马齿苋5克、马蔺子6克、天茄子6克、无爷藤8克、无患子6克、木芙蓉花6克、瓦松3克、毛莨1克、凤尾草6克、水蓼2克、龙葵6克、白蔹5克、白毛藤6克、白薯莨1克、玄参2克、半边莲6克、草血竭3克和甘草9克,将以上48味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗瘀血型腋下急性化脓性淋巴结炎的中药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103675517A CN103432483A (zh) | 2013-08-22 | 2013-08-22 | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103675517A CN103432483A (zh) | 2013-08-22 | 2013-08-22 | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103432483A true CN103432483A (zh) | 2013-12-11 |
Family
ID=49686267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103675517A Pending CN103432483A (zh) | 2013-08-22 | 2013-08-22 | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103432483A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105535290A (zh) * | 2015-09-17 | 2016-05-04 | 陶文苹 | 一种治疗化脓性门静脉炎的中药 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102631632A (zh) * | 2012-04-03 | 2012-08-15 | 张成玲 | 一种治疗瘀血型足底疔的中药洗剂制备方法 |
| CN102671112A (zh) * | 2012-02-27 | 2012-09-19 | 李义军 | 一种治疗瘀血型臁疮的中药制备方法 |
-
2013
- 2013-08-22 CN CN2013103675517A patent/CN103432483A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102671112A (zh) * | 2012-02-27 | 2012-09-19 | 李义军 | 一种治疗瘀血型臁疮的中药制备方法 |
| CN102631632A (zh) * | 2012-04-03 | 2012-08-15 | 张成玲 | 一种治疗瘀血型足底疔的中药洗剂制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105535290A (zh) * | 2015-09-17 | 2016-05-04 | 陶文苹 | 一种治疗化脓性门静脉炎的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102302741B (zh) | 一种治疗心血瘀阻型胸痹的中药制备方法 | |
| CN102631632B (zh) | 一种治疗瘀血型足底疔的中药洗剂制备方法 | |
| CN103463523B (zh) | 一种治疗热毒炽盛型腋下急性化脓性淋巴结炎中药 | |
| CN102366547B (zh) | 一种治疗便秘型褥疮的中药洗剂制备方法 | |
| CN102579772B (zh) | 一种治疗痰浊壅塞型臁疮的中药洗剂制备方法 | |
| CN103432483A (zh) | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN102671112B (zh) | 一种治疗瘀血型臁疮的中药制备方法 | |
| CN103099980A (zh) | 一种治疗肝郁型巩膜炎的中药制备方法 | |
| CN103463337B (zh) | 一种治疗经络阻滞型腋下急性化脓性淋巴结炎的中药 | |
| CN103446359A (zh) | 一种治疗过食肥肉型前庭大腺炎的中药洗剂制备方法 | |
| CN103463433A (zh) | 一种治疗口渴型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103463434A (zh) | 一种治疗发热型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432407B (zh) | 一种治疗过食猪肝型腋下急性化脓性淋巴结炎的中药 | |
| CN103432409B (zh) | 一种治疗嗜食烤肉型腋下急性化脓性淋巴结炎的中药 | |
| CN103432454A (zh) | 一种治疗酗酒型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432408B (zh) | 一种治疗痰浊壅塞型腋下急性化脓性淋巴结炎的中药 | |
| CN103432451B (zh) | 一种治疗过食猪大肠型腋下急性化脓性淋巴结炎的中药 | |
| CN103432405B (zh) | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 | |
| CN103432406A (zh) | 一种治疗肿块型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN102614455B (zh) | 一种治疗疼痛型臁疮的中药洗剂制备方法 | |
| CN103230553A (zh) | 一种治疗渗出型脓性指头炎的中药洗剂制备方法 | |
| CN102552826A (zh) | 一种治疗腹胀型臁疮的中药洗剂制备方法 | |
| CN103463558A (zh) | 一种治疗肝郁型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432404A (zh) | 一种治疗嗜食辣椒型腋下急性化脓性淋巴结炎的中药 | |
| CN103446397A (zh) | 一种治疗过食肥肉型腋下急性化脓性淋巴结炎的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131211 |